Skip to main content
See every side of every news story
Published loading...Updated

Man sees deadly brain tumour shrink by half thanks to new radioactive therapy

  • A man has seen his deadly brain tumour shrink by half thanks to a new radioactive therapy, which experts hope will eradicate the disease.
  • Paul Read, a 62-year-old engineer from Luton, is the first patient to take part in the trial and has seen his tumour shrink in half in a matter of weeks.
  • Dr. Paul Mulholland, UCLH consultant medical oncologist who designed the trial, said the reduction of Mr. Read's tumour 'is really quite remarkable for somebody whose tumour is so aggressive.'
  • Researchers plan to combine ATT001 with immunotherapy, which trains the body's immune system to kill cancerous cells.
Insights by Ground AI

16 Articles

PerthNowPerthNow
Reposted by
The West AustralianThe West Australian
Center

Imaging technique offers hope for brain cancer patients

Researchers have developed an imaging technique to help spot which brain cancer patients will benefit from immunotherapy drugs.

·City of Perth, Australia
Read Full Article
Evening StandardEvening Standard
+4 Reposted by 4 other sources
Center

Man sees deadly brain tumour shrink by half thanks to new radioactive therapy

University College London Hospitals NHS Foundation Trust is leading a new clinical trial to treat glioblastoma.

·London, United Kingdom
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 40% of the sources are Center
40% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Independent broke the news in London, United Kingdom on Tuesday, October 29, 2024.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal